期刊文献+

人重组促红细胞生成素增强耐缺氧作用的实验研究 被引量:2

Study on enhancing anoxia endurance function of recombinant human erythropoietin in mice
下载PDF
导出
摘要 目的观察人重组促红细胞生成素(EPO)对小鼠缺氧耐受力的影响。方法小鼠随机分为EPO组和对照组,经皮下注射不同剂量的EPO和0.9%氯化钠注射溶液,1次/d,连续1周。检测小鼠血红蛋白、红细胞比容改变,测定常压耐氧实验、亚硝酸中毒存活试验以及急性脑缺血性缺氧试验等指标。结果EPO能明显增加小鼠血液内血红蛋白含量和红细胞比容(与对照组相比,P<0.01),缺氧存活时间显著延长(与对照组相比,P<0.01)。结论EPO能明显增强机体的耐缺氧能力。 Objective To observe the effects of EPO on hypoxia tolerance in mice. Methods The mice were randomly divided into EPO-treated group and control group, the mice were subcutaneous injection administered different doses of EPO or normal saline respectively once a day for 7 days. Then, the levels of hemoglobin and hematocrit were determined. The survival times of acute hypoxia were measured in anoxia with normal air pressure,in poisoning by nitrite and in acute lack of blood in brain. Results The levels of hemoglobin and hematocrit in EPO group were markedly increased,compared with those of control group,P 〈 0.01, and the survival times of hypoxia in mice were significantly prolonged, compared with control group, P 〈 0.01. Conclusion EPO has a remarkable effect in enhancing the tolerance of hypoxia in the mice.
出处 《中国临床保健杂志》 CAS 2009年第4期394-396,共3页 Chinese Journal of Clinical Healthcare
基金 全军医药卫生科研基金课题(01MA031)
关键词 红细胞生成素 重组 缺氧 小鼠 Erythropoietin, recombinant Anoxia Mice
  • 相关文献

参考文献6

二级参考文献22

  • 1黄树其,邵福源.促红细胞生成素对血管性痴呆大鼠认知功能的影响[J].医学临床研究,2006,23(5):653-655. 被引量:6
  • 2张彦博.高原疾病[M].西宁:青海人民出版社,1992.3.
  • 3[1]Joyeux-Faure M,Godin Ribuot D,Ribuot C.Erythropoie-tin and myocardial protection:what's new[J].Fundam Clin Pharmacol,2005,19 (4):439-446.
  • 4[2]Chatterjee PK.Pleiotropic renal actions of erythropoietin[J].Lancet,2005,365(9474):1890-1892.
  • 5[4]Bahlmann FH,Song R,Boehm SM,et al.Low-dose ther-apy with the long-acting erythropoietin analogue darbepo-etin alpha persistently activates endothelial Akt and atten-uates progressive organ failure[J].Circulation,2004,110 (8):1006-1012.
  • 6[5]Sepodes B,Maio R,Pinto R,et al.Recombinant human erythropoietin protects the liver from hepatic ischemia-reperfusion injury in the rat[J].Transpl Int,2006,19(11):919-926.
  • 7[6]Xu B,Dong GH,Liu H,et al.Recombinant human eryth-ropoietin pretreatment attenuates myocardial infarct size:a possible mechanism involves heat shock Protein 70 and attenuation of nuclear factor-kappaB[J].Ann Clin Lab Sci,2005,35(2):161-168.
  • 8[7]Miki T,Miura T,Yano T,et al.Alteration in erythropoie-tin-induced cardioprotective signaling by postinfarct ven-tricular remodeling[J].J Pharmacol Exp Ther,2006,317(1):68-75.
  • 9[8]Tramontano AF,Muniyappa R,Black AD,et al.Erythro-poietin protects cardiac myocytes from hypoxia-induced apoptosis through an Akt-dependent pathway[J].Biochem Biophys Res Commun,2003,308(4):990-994.
  • 10[9]Ammarguellat F,Llovera M,Kelly PA,et al.Low doses of EPO activate MAP kinases but not JAK22STAT5 in rat vascular smooth muscle cells[J].Biochem Biophys Res Commun,2001,284 (4):1031-1038.

共引文献186

同被引文献19

  • 1许丹,张春来,李霞,纪征,刘长青,卢峰,姜玉凤,姜玉如,尚小明.制作大鼠急性心肌梗死模型的实验分析[J].中国煤炭工业医学杂志,2006,9(2):190-191. 被引量:9
  • 2饶婷,张孝斌,吴飞,杨吉伟,董万超.Bcl-2在大鼠肾上腺髓质增生组织中的表达及意义[J].实用医学杂志,2006,22(6):634-636. 被引量:3
  • 3Sharov VG, Sabbah HN, Shimoyama H, et al. Evidence of cardiocyte apoptosis in myocardium of dogs with chronic heart failure. Am J Pathol,1996,148(1 ) :141-149.
  • 4Tramontano AF, Muniyappa R, Black AD ,et al. Erythropoietin protects cardiac myocytes from hytioxia-indueed apoptosis through an Akt-dependent pathway. Biochem Biophys Res Commun ,2003,308 (4) :990-994.
  • 5Maiese K, Li F, Chong ZZ, et al. Erythropoietin in the brain : can the promise to protect be fulfilled?. Trends Pharmacol Sci ,2004,25 (11) :577-583.
  • 6Aikawa R, Komuro I, Yamazaki T, et al. Oxidative stress activates extracellular sigual-regulated kinases through Src and Ras in cultured cardiac myocytes of neonatal rats. J Clin Invest, 1997,100 (7) :1813-1821.
  • 7Bemecker OY, Huq F, Heist EK, et al. Apoptosis in heart failure and the seneseen! heart. Cardiovase Toxico1,2003,3 ( 3 ) : 183-190.
  • 8Karnofsky D A. The use of the nitrogenmustards in the pallia-tive treatment of carcinoma [ J ]. Cancer, 1948, 1(4) :63d- 656.
  • 9Cortesi E, Mancuso A, De Pasquale Ceratti A, et al. Efectivencss and safety of an induction therapy with epoetin alfa in anemic cancer patients receiving concomitant chemotherapy [ J ]. Oncologist,2004,9(4) :459- 468.
  • 10Quirt I,Robeson C,Lau C Y,et al. Epoetin alfa therapy increases hemoglobin levels and improves quality of life in patients with cancer-related anemia who are not receiving chemotherapy and patients with anemia who are receiving chemotherapy [ J ]. Clin Oncol,2001,19(7) :4126- 4134.

引证文献2

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部